Quantum-Si incorporated (QSI) Research

Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.

Market snapshot

Symbol
QSI
Price
$1.00
Day change
+5.79%
Market cap
$197.6M
P/E ratio
-2.08x
52-week range
0.691-3.1
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$1.00

Peer companies

  • ADC Therapeutics S.A. (ADCT)
  • Altimmune, Inc. (ALT)
  • Annexon, Inc. (ANNX)
  • Aura Biosciences, Inc. (AURA)
  • Autolus Therapeutics plc (AUTL)
  • DBV Technologies S.A. (DBVT)
  • enGene Holdings Inc. (ENGN)
  • LB Pharmaceuticals Inc Common Stock (LBRX)

Recent insider activity

  • Makes Brigid — A-Award (251185 shares) on 2026-05-18
  • Fattori Ruth A — A-Award (251185 shares) on 2026-05-18
  • Dowdy Paula — A-Award (251185 shares) on 2026-05-18
  • Jafri Amir — A-Award (251185 shares) on 2026-05-18
  • Kenny John P. — A-Award (251185 shares) on 2026-05-18

Open Quantum-Si incorporated (QSI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.